It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Hereditary distal renal tubular acidosis (dRTA) is a rare disease of H+ excretion defect of α-intercalated cells in renal collecting duct, caused by decreased V-ATPase function due to mutations in the ATP6V1B1 or ATP6V0A4 genes. In the present study, a genetic family with 5 members of the complete dRTA phenotype were found with distal tubule H+ secretion disorder, hypokalemia, osteoporosis, and kidney stones. A variant NM_020632.2:c.1631C > T (p.Ser544Leu) in exon 16 on an ATP6V0A4 gene associated with dRTA was detected by next generation sequencing target region capture technique and verified by Sanger sequencing, which suggested that except for one of the patients who did not receive the test, the other four patients all carried the p.S544L heterozygote. In transfected HEK293T cells, cells carrying p.S544L-mut showed early weaker ATPase activity and a slower Phi recovery rate after rapid acidification. By immunofluorescence localization, it was observed that the expression level of p.S544L-mut on the cell membrane increased and the distribution was uneven. Co-immunoprecipitation showed the a4 subunit of ATP6V0A4/p.S544L-mut could not bind to the B1 subunit, which might affect the correct assembly of V-ATPase. The present study of dRTA family suggests that the p.S544L variant may be inherited in a dominant manner.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China (GRID:grid.256112.3) (ISNI:0000 0004 1797 9307); Fujian Provincial Hospital, Department of Traditional Chinese Medicine, Fuzhou, China (GRID:grid.415108.9) (ISNI:0000 0004 1757 9178)
2 Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China (GRID:grid.256112.3) (ISNI:0000 0004 1797 9307)
3 the First Affiliated Hospital, Fujian Medical University, Department of Traditional Chinese Medicine, Fuzhou, China (GRID:grid.412683.a) (ISNI:0000 0004 1758 0400)
4 Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China (GRID:grid.256112.3) (ISNI:0000 0004 1797 9307); Fujian Provincial Hospital, Department of Paediatrics, Fuzhou, China (GRID:grid.415108.9) (ISNI:0000 0004 1757 9178)
5 Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China (GRID:grid.256112.3) (ISNI:0000 0004 1797 9307); Fujian Provincial Hospital, Department of Interventional Radiology, Fuzhou, China (GRID:grid.415108.9) (ISNI:0000 0004 1757 9178)